Xometry, Inc. Earnings Per Share Disclosure
(10) Net Loss Per Share Attributable to Common Stockholders
The Company computes net loss per share of Class A common stock, Class B common stock and participating securities using the two-class method. Basic and diluted earnings per share are the same for each class of common stock and participating securities because they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data):
|
|
Year Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Net loss |
|
$ |
(61,748 |
) |
|
$ |
(50,403 |
) |
|
$ |
(67,465 |
) |
Net (loss) income attributable to noncontrolling interest |
|
|
(5 |
) |
|
|
(2 |
) |
|
|
7 |
|
Net loss attributable to common stockholders |
|
$ |
(61,743 |
) |
|
$ |
(50,401 |
) |
|
$ |
(67,472 |
) |
|
|
|
|
|
|
|
|
|
|
|||
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted, of Class A and Class B common stock |
|
|
50,812,072 |
|
|
|
49,082,722 |
|
|
|
47,914,039 |
|
Net loss per share attributable to common stockholders, basic and diluted, of Class A and Class B common stock |
|
$ |
(1.22 |
) |
|
$ |
(1.03 |
) |
|
$ |
(1.41 |
) |
The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share because including them would have had an anti-dilutive effect, or issuance of such shares is contingent upon the occurrence of an event:
|
|
December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Stock options outstanding |
|
|
1,479,226 |
|
|
|
1,906,483 |
|
|
|
2,881,208 |
|
Unvested RSUs |
|
|
2,912,677 |
|
|
|
2,530,358 |
|
|
|
1,769,874 |
|
Unvested PRSUs |
|
|
468,715 |
|
|
|
272,515 |
|
|
|
— |
|
Warrants outstanding |
|
|
— |
|
|
|
— |
|
|
|
87,784 |
|
Shares reserved for charitable contribution |
|
|
80,530 |
|
|
|
161,062 |
|
|
|
241,594 |
|
2027 Notes |
|
|
1,529,157 |
|
|
|
5,123,624 |
|
|
|
5,123,624 |
|
2030 Notes |
|
|
5,312,375 |
|
|
|
— |
|
|
|
— |
|
Total shares |
|
|
11,782,680 |
|
|
|
9,994,042 |
|
|
|
10,104,084 |
|
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 24, 2026 | Showing above |
| 2024 | Feb 25, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Mar 16, 2023 | |
| 2021 | Mar 18, 2022 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.